The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
The justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone. They are appealing a lower court ruling that would roll back Food and Drug Administration approval of mifepristone.
For more: [ Ссылка ]
►Subscribe: [ Ссылка ]
►Website: [ Ссылка ]
►Facebook: [ Ссылка ]
►Twitter: [ Ссылка ]
